View in EDS PDF Full Text

Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial.

Saved in:
Bibliographic Details
Title: Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial.
Authors: Hockham, Carinna1,2 (AUTHOR), Kotwal, Sradha1,3 (AUTHOR), Wilcox, Arlen1,4 (AUTHOR) arlen.wilcox@sydney.edu.au, Bassi, Abhinav5 (AUTHOR), McGree, James6 (AUTHOR), Pollock, Carol7,8 (AUTHOR), Burrell, Louise M.9 (AUTHOR), Bathla, Nikita5 (AUTHOR), Kunigari, Mallikarjuna5 (AUTHOR), Rathore, Vinay10 (AUTHOR), John, Michael11 (AUTHOR), Lin, Enmoore1 (AUTHOR), Jenkins, Christine1,12 (AUTHOR), Ritchie, Angus12 (AUTHOR), McLachlan, Andrew12,13 (AUTHOR), Snelling, Thomas14,15 (AUTHOR), Jones, Mark14 (AUTHOR), Jha, Vivekanand1,5 (AUTHOR), Jardine, Meg1,4 (AUTHOR), CLARITY Investigators (CORPORATE AUTHOR)
Source: Trials. 8/28/2021, Vol. 22 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Description
ISSN:17456215
DOI:10.1186/s13063-021-05521-0